Narcotic Abuse: Clinical Trials

20 trials for Narcotic Abuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 6 unknown, 1 terminated. 2 Phase 1, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Completed 1
Phase 41Terminated 1

Follow Narcotic Abuse: new trials by email Literature Review of Narcotic Abuse trials Research Report on Narcotic Abuse

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries
Questionnaire - Narcotic Use, Postoperative Pain
CompletedSt. Louis University2232017-11-162021-09-24
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
Observation Only - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium36002017-11-012025-01-29
Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain
Structured discontinuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER), Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER) - Opioid-Related Disorders, Opiate Addiction
Phase 4TerminatedMember Companies of the Opioid PMR Consortium442016-09-142019-11-06
Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication
Psychiatric Research Interview for Substance and Mental Disorders (PRISM-5-Op) - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium6062015-11-172020-06-16
An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data
Algorithm to identify patients experiencing opioid abuse/addiction - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium16672015-05-202020-04-15
Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B
Algorithm to determine overdose from opioid abuse - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium27012015-04-072020-04-15
A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire
Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium8002015-04-072020-04-15
Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or Addiction
DB review for Doctor/Pharmacy Shopping Behavior - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium1649232015-02-052020-04-15
A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire
Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium542015-01-022020-04-15
A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
Survey to Eval Relation between Shopping and Misuse, Abuse - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium10852014-11-072020-04-15
Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review
Medical Record Review - Opioid-Related Disorders, Opiate Addiction
CompletedMember Companies of the Opioid PMR Consortium5902014-11-062020-04-15
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo
Placebo, EMBEDA - morphine sulfate/ naltrexone hydrochloride, morphine sulfate CR crushed. - Narcotic Abuse, Opioid-related Disorders
Phase 1CompletedPfizer332010-08-012012-06-08
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
oxycodone hydrochloride, marketed oxycodone hydrochloride - Analgesia, Acute Pain
Phase 1CompletedPfizer352010-07-012012-02-24
Aprepitant Effects on Oxycodone Response
Aprepitant 0mg, Aprepitant 40mg, Aprepitant 200mg - Narcotic Abuse
Not applicableCompletedSharon Walsh92009-10-012017-09-01
Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products
Non-interventional study - retrospective database review - Opioid Related Disorders, Opiate Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)55758342016-10-06
ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning
Retrospective database review - Opioid-related Disorders, Opioid Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)1834522016-10-05
Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics
Non-interventional study - retrospective database review - Opioid Related Disorders, Opiate Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)3600002016-09-30
Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers
on-interventional study - retrospective database review - Opioid Related Disorders, Opiate Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)55758342016-09-30
ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases
Surveillance of state medical examiner databases - Opioid-related Disorders, Opioid Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)130152016-09-13
Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers
Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System of post-marketing surveillance of prescription medication abuse, misuse, and diversion - Opioid-related Disorders, Opioid Addiction
UnknownER/LA Opioid REMS Program Companies (RPC)265002016-08-25

Narrower conditions

Narcotic-Related Disorders (20)  ·  Opioid-Related Disorders (19)  ·  Substance-Related Disorders (16)  ·  Agnosia (2)  ·  Chronic Pain (2)  ·  Acute Pain (1)  ·  Musculoskeletal Diseases (1)  ·  Pain, Postoperative (1)  ·  Recreational Drug Use (1)

Broader conditions

Chemically-Induced Disorders (20)  ·  Mental Disorders (20)  ·  Substance-Related Disorders (4)  ·  Neurologic Manifestations (3)  ·  Pain (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Perceptual Disorders (2)  ·  Behavior (1)  ·  Pathologic Processes (1)  ·  Postoperative Complications (1)

Interventions

Oxycodone (2)  ·  Aprepitant (1)  ·  Naltrexone (1)  ·  Surveys and Questionnaires (1)

Sponsors

Member Companies of the Opioid PMR Consortium (10)  ·  ER/LA Opioid REMS Program Companies (RPC) (6)  ·  Pfizer (2)  ·  Sharon Walsh (1)  ·  St. Louis University (1)

Countries

United States (6)

Top investigators

Soledad Cepeda, MD, PhD (3)  ·  Alexandra Barsdorf, Ph.D. (2)  ·  Kenneth R Petronis (2)  ·  Paul Coplan, MS, ScD, MBA (2)  ·  John M Capelle, MD (1)  ·  Sharon L Walsh, Ph.D. (1)

Results publications

PMID 22260216, PMID 22717418, PMID 23936895, PMID 27869630, PMID 31020755, PMID 31095831, PMID 31218780, PMID 31534380, PMID 32489718, PMID 35437075, PMID 35702830

NIH funding

R01DA027031 (1)